Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Condensed Consolidated Statements of Operations and Comprehensive Loss
Revenues, net	$ 41,189	$ 50,603
Revenue, Product and Service [Extensible Enumeration]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of revenues	$ 26,041	$ 37,987
Cost, Product and Service [Extensible Enumeration]	us-gaap:ProductMember	us-gaap:ProductMember
Gross profit	$ 15,148	$ 12,616
Operating expense:
General and administrative	14,731	15,457
Research and development	597	613
Total operating expense	15,328	16,070
Loss from operations	(180)	(3,454)
Other income (expense):
Interest expense, net	(2,447)	(2,317)
Other expense, net	(22)	(15)
Gain on settlement of liabilities, net		854
Change in fair value of derivative liabilities	(224)	(10)
Total other expense	(2,693)	(1,488)
Loss before income taxes	(2,873)	(4,942)
Income tax (expense) benefit	(51)	86
Net loss	(2,924)	(4,856)
Fixed dividends - Series B Preferred	(317)	(317)
Net loss attributable to common stockholders	(3,241)	(5,173)
Comprehensive loss:
Net loss	(2,924)	(4,856)
Foreign currency translation adjustment	558	(1,772)
Total comprehensive loss	$ (2,366)	$ (6,628)
Net loss per common share - basic	$ (0.04)	$ (0.07)
Net loss per common share - diluted	$ (0.04)	$ (0.07)
Weighted average number of common shares outstanding - basic	74,931	65,428
Weighted average number of common shares outstanding - diluted	74,931	65,428